MEDA: Difference between revisions

MEDA
Names
	Preferred IUPAC name 1-(8-Methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
Identifiers
CAS Number	23693-25-6 ;
3D model (JSmol)	Interactive image;
ChemSpider	24034 ;
KEGG	D03376 ;
PubChem CID	25798;
UNII	T2DAA4TB22 ;
	InChI InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 Key: NRVFDGZJTPCULU-UHFFFAOYSA-N ; InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 Key: HEYPARQBPGSFKW-UHFFFAOYSA-N;
	SMILES NC(CC1=CC2=C(OCCO2)C(OC)=C1)C;
Properties
Chemical formula	C12H17NO3
Molar mass	223.272 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Browse history interactively

← Previous edit

Content deleted Content added

VisualWikitext

Inline

Latest revision as of 02:08, 22 August 2022

MEDA (3-methoxy-4,5-ethylenedioxyamphetamine) is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown.^[1] MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.

References

^ MEDA entry in PiHKAL

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.

[1] MEDA entry in PiHKAL

[1]

@@ Line 1: / Line 1: @@
+{{About|the psychedelic drug|the instrument on the Perseverance rover|Mars Environmental Dynamics Analyzer}}
+{{one source|date=July 2019}}
 {{chembox
 | Verifiedfields = changed
@@ Line 5: / Line 7: @@
 | ImageFile = MEDA.png
 | ImageSize = 200px
-| IUPACName = 1-(8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
+| PIN = 1-(8-Methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
 | OtherNames =
 |Section1={{Chembox Identifiers
@@ Line 20: / Line 22: @@
 | CASNo_Ref = {{cascite|correct|??}}
 | CASNo = 23693-25-6
+| UNII_Ref = {{fdacite|correct|FDA}}
+| UNII = T2DAA4TB22
 | PubChem = 25798
 | SMILES = NC(CC1=CC2=C(OCCO2)C(OC)=C1)C
 }}
 |Section2={{Chembox Properties
+| C=12
-| Formula = C<sub>12</sub>H<sub>17</sub>NO<sub>3</sub>
+| H=17
-| MolarMass = 223.268 g/mol
+| N=1
+| O=3
 | Appearance =
 | Density =
@@ Line 37: / Line 43: @@
 }}
-'''MEDA''', or '''3-[[methoxy]]-4,5-[[ethylene]]di[[Ketone|oxy]][[amphetamine]]''', is a lesser-known [[Psychedelics, dissociatives and deliriants|psychedelic drug]]. MEDA was first synthesized by [[Alexander Shulgin]]. In his book ''[[PiHKAL|PiHKAL (Phenethylamines i Have Known And Loved)]]'', the minimum dosage is listed as 200&nbsp;mg, and the duration unknown. MEDA produces few to no effects.  Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.
+'''MEDA''' ('''3-methoxy-4,5-ethylenedioxyamphetamine''') is a lesser-known [[Psychedelics, dissociatives and deliriants|psychedelic drug]]. MEDA was first synthesized by [[Alexander Shulgin]]. In his book ''[[PiHKAL]]'', the minimum dosage is listed as 200&nbsp;mg, and the duration unknown.<ref>[http://www.erowid.org/library/books_online/pihkal/pihkal120.shtml MEDA entry in ''PiHKAL'']</ref> MEDA produces few to no effects.  Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.
 == See also ==
@@ Line 44: / Line 50: @@
 * [[Psychedelics, dissociatives and deliriants]]
-== External links ==
+== References ==
+{{reflist}}
-* [http://www.erowid.org/library/books_online/pihkal/pihkal120.shtml MEDA entry in ''PiHKAL'']
-* [http://pihkal.info/read.php?domain=pk&id=120 MEDAentry in PiHKAL • info]
-{{PiHKAL}}
 [[Category:Substituted amphetamines]]